Business Focus
Business Plan
Business Conceptualization
Market Summary
Finished Dosages
Business PlanObjectives:
Develop ANDAs (Generic version of Off-Patented Branded Drugs) to US market.
Develop Generic Drug Products to other Global Markets.
Contract Manufacture Pharmaceutical Drug Products to other Companies.

Achievements:
USFDA Approved Generic Bactrim (Sulfamethoxazole + Trimethoprim - SMZ) for US Market in October 2005.
SMZ Product(Generic Bactrim) is First Manufactured in US in 2006.
SMZ Product (Generic Bactrim) is First launched in US in May 2006.
USFDA approved the Site Transfer of SMZ Product Manufacturing to India in June 2010.
SMZ Product from India is launched in US in November 2010.
   
Research &
Development
   
Click here
to see
Our Products